News Coverage 11.13.19 By: Marta Figueiredo Share on Twitter Share on Facebook Share on LinkedIn CRISPR-edited T-cells Safely, Effectively Target Cancer Cells in Myeloma Patients, Early Phase 1 Data Suggests Related Announcement, Press Release Parker Institute for Cancer Immunotherapy Announces Appointment of Bob Purcell as Chief Communications Officer Announcement, Press Release Parker Institute for Cancer Immunotherapy Collaborates with Conquer Cancer and ASCO to Support Promising Cancer Research Announcement Parker Institute for Cancer Immunotherapy Announces Appointment of Mark Veich as Chief Organizational Advancement Officer
Announcement, Press Release Parker Institute for Cancer Immunotherapy Announces Appointment of Bob Purcell as Chief Communications Officer
Announcement, Press Release Parker Institute for Cancer Immunotherapy Collaborates with Conquer Cancer and ASCO to Support Promising Cancer Research
Announcement Parker Institute for Cancer Immunotherapy Announces Appointment of Mark Veich as Chief Organizational Advancement Officer